Becker's Healthcare August 27, 2025
Alexandra Murphy

The FDA has approved Pfizer and BioNTech’s updated COVID-19 vaccine for adults 65 and older along with individuals ages 5-64 who are at increased risk of severe COVID-19.

The new formulation targets several SARS-CoV-2 sublineages, aligning with the FDA guidance to better match circulating strains expected during the 2025-2026 virus season, according to an Aug....

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID
FDA guidance eases wearables oversight. But experts have questions about what’s next.
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter

Share Article